Research Summary
Analyzed using Evidence Intelligence™

Digital intervention improves hypoglycemia management in adults with T1D

Last updated September 9, 2026

Key finding

All participants completed the intervention.

The HypoPals study evaluated a digital behavioral intervention for managing hypoglycemia in adults with Type 1 Diabetes, finding high retention and acceptability among participants.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Risk of bias

High Risk

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

The HypoPals study evaluated a digital behavioral intervention for managing hypoglycemia in adults with Type 1 Diabetes, finding high retention and acceptability among participants.

Clinical relevance

Effective management of hypoglycemia is crucial for individuals with Type 1 Diabetes, as it can prevent severe health complications. The high retention and acceptability rates of the HypoPals intervention indicate that digital behavioral strategies may enhance patient engagement and improve outcomes in managing hypoglycemia.

Keep in mind

Effectiveness of the intervention remains unclear due to lack of specific outcomes. The study did not include a control group for comparison. Findings may not be generalizable to all populations with Type 1 Diabetes.

Published in

Journal Reference

Publication details and source links for this paper.

Yu KL, Emily H, Juniar L, et al. HypoPals: A Digital Behavioral Intervention for Hypoglycemia Management in Adults with Type 1 Diabetes. Contemporary clinical trials. 2026;163:108261-108261. doi:10.1016/j.cct.2026.108261

Main Effects

All participants completed the intervention.

Retention rates were 98% at both 26 and 52 weeks.

88% of participants found the HypoPals intervention at least somewhat helpful.

No adverse events related to the intervention were reported.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Hypoglycemia symptom detection training (SDT) and Acceptability of mHealth intervention, Adverse events incidence, Proportion of participants completing the dietary intervention, and 2 more.

Primary intervention

Hypoglycemia symptom detection training (SDT)

Primary outcomes

  • Acceptability of mHealth intervention
  • Adverse events incidence
  • Proportion of participants completing the dietary intervention

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

5
Evidence pairs
5
Relationships
0
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 54

0

Related topics

5

Evidence pairs

0

Related studies

Why it is useful

  • Contributes to 5 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Core evidence

Study findings

The primary outcomes reported in this study.

Acceptability of mHealth intervention

Hypoglycemia symptom detection training (SDT) → Acceptability of mHealth intervention

Hypoglycemia symptom detection training (SDT) → Acceptability of mHealth intervention

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Adverse events incidence

Hypoglycemia symptom detection training (SDT) → Adverse events incidence

Hypoglycemia symptom detection training (SDT) → Adverse events incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Proportion of participants completing the dietary intervention

Hypoglycemia symptom detection training (SDT) → Proportion of participants completing the dietary intervention

Hypoglycemia symptom detection training (SDT) → Proportion of participants completing the dietary intervention

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Retention rate at 26 weeks

Hypoglycemia symptom detection training (SDT) → Retention rate at 26 weeks

Hypoglycemia symptom detection training (SDT) → Retention rate at 26 weeks

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Retention rate at 52 weeks

Hypoglycemia symptom detection training (SDT) → Retention rate at 52 weeks

Hypoglycemia symptom detection training (SDT) → Retention rate at 52 weeks

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • All participants completed the intervention, indicating high engagement.
  • Retention rates were consistently high at 98% over 52 weeks.
  • 88% of participants reported the intervention was helpful.
who this applies

Who this applies to

  • Adults with Type 1 Diabetes.
  • Individuals experiencing hypoglycemia management challenges.
keep in mind

Keep in Mind

  • The study's effectiveness outcomes are not clearly defined.
  • Results may not apply to younger populations or those with Type 2 Diabetes.
  • Further research is needed to confirm the long-term benefits of the intervention.
between the lines

Between the Lines

  • Effectiveness of the intervention remains unclear due to lack of specific outcomes.
  • The study did not include a control group for comparison.
  • Findings may not be generalizable to all populations with Type 1 Diabetes.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Hypoglycemia symptom detection training (SDT) and Acceptability of mHealth intervention, Hypoglycemia symptom detection training (SDT) and Adverse events incidence.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Explore more in Evidence Explorer

Jump to pre-filtered views in Evidence Explorer.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Hypoglycemia symptom detection training (SDT) improve proportion of participants completing the dietary intervention?

Emerging Evidence

Hypoglycemia symptom detection training (SDT) appears to improve proportion of participants completing the dietary intervention.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Proportion of participants completing the dietary intervention

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Hypoglycemia symptom detection training (SDT) improve retention rate at 26 weeks?

Emerging Evidence

Hypoglycemia symptom detection training (SDT) appears to improve retention rate at 26 weeks.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Retention rate at 26 weeks

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Hypoglycemia symptom detection training (SDT) improve retention rate at 52 weeks?

Emerging Evidence

Hypoglycemia symptom detection training (SDT) appears to improve retention rate at 52 weeks.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Retention rate at 52 weeks

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Hypoglycemia symptom detection training (SDT) improve acceptability of mhealth intervention?

Emerging Evidence

Current evidence does not show a clear benefit of Hypoglycemia symptom detection training (SDT) for acceptability of mhealth intervention.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Acceptability of mHealth intervention

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.